Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1993 May;35(5):517–524. doi: 10.1111/j.1365-2125.1993.tb04178.x

The effect of captopril on the superior mesenteric artery and portal venous blood flow in normal man.

K Ray-Chaudhuri 1, T Thomaides 1, S Maule 1, L Watson 1, S Lowe 1, C J Mathias 1
PMCID: PMC1381690  PMID: 8099804

Abstract

1. Measurements of superior mesenteric artery and portal venous blood flow were made non-invasively along with systemic and other regional (cardiac index, forearm and cutaneous blood flow) vascular responses to acute ingestion of the ACE inhibitor captopril (50 mg) or placebo (50 mg vitamin C), in 12 healthy subjects while supine and during head-up tilt. 2. After captopril, superior mesenteric artery and portal blood flow rose markedly with a reduction in superior mesenteric artery vascular resistance. Supine blood pressure was unchanged but cardiac index and forearm blood flow rose; during head-up tilt, blood pressure fell in some subjects. 3. There was a rise in levels of plasma renin activity and a fall in levels of plasma angiotensin II after captopril. After placebo, there were no significant changes in splanchnic blood flow, systemic or other regional responses and in biochemical measurements, while supine. 4. Our studies indicate that captopril is a potent dilator of the splanchnic vascular bed and suggest that this action may contribute to its therapeutic effects. The studies indicate a role for angiotensin II in the control of this large vascular bed although other agents (bradykinin, prostacyclin) may contribute.

Full text

PDF
517

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Banas J. S., Jr Effects of inhibitors of angiotensin-converting enzyme on regional hemodynamics. Am J Cardiol. 1992 Apr 2;69(10):40C–45C. doi: 10.1016/0002-9149(92)90280-c. [DOI] [PubMed] [Google Scholar]
  2. Boyd G. W., Fitz A. E., Adamson A. R., Peart W. S. Radioimmunoassay determination of plasma-renin activity. Lancet. 1969 Feb 1;1(7588):213–218. doi: 10.1016/s0140-6736(69)91237-9. [DOI] [PubMed] [Google Scholar]
  3. Brown H. S., Halliwell M., Qamar M., Read A. E., Evans J. M., Wells P. N. Measurement of normal portal venous blood flow by Doppler ultrasound. Gut. 1989 Apr;30(4):503–509. doi: 10.1136/gut.30.4.503. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bulkley G. B., Oshima A., Bailey R. W., Horn S. D. Control of gastric vascular resistance in cardiogenic shock. Surgery. 1985 Aug;98(2):213–223. [PubMed] [Google Scholar]
  5. CAESAR J., SHALDON S., CHIANDUSSI L., GUEVARA L., SHERLOCK S. The use of indocyanine green in the measurement of hepatic blood flow and as a test of hepatic function. Clin Sci. 1961 Aug;21:43–57. [PubMed] [Google Scholar]
  6. Chaudhuri K. R., Thomaides T., Hernandez P., Alam M., Mathias C. J. Noninvasive quantification of superior mesenteric artery blood flow during sympathoneural activation in normal subjects. Clin Auton Res. 1991 Mar;1(1):37–42. doi: 10.1007/BF01826056. [DOI] [PubMed] [Google Scholar]
  7. Chaudhuri K. R., Thomaides T., Mathias C. J. Abnormality of superior mesenteric artery blood flow responses in human sympathetic failure. J Physiol. 1992 Nov;457:477–489. doi: 10.1113/jphysiol.1992.sp019388. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Clark R. A., Colley D. P., Jacobson E. D., Herman R., Tyler G., Stahl D. Superior mesenteric angiography and blood flow measurement following intra-arterial injection of prostaglandin E1. Radiology. 1980 Feb;134(2):327–333. doi: 10.1148/radiology.134.2.7352210. [DOI] [PubMed] [Google Scholar]
  9. Clough D. P., Collis M. G., Conway J., Hatton R., Keddie J. R. Interaction of angiotensin-converting enzyme inhibitors with the function of the sympathetic nervous system. Am J Cardiol. 1982 Apr 21;49(6):1410–1414. doi: 10.1016/0002-9149(82)90352-6. [DOI] [PubMed] [Google Scholar]
  10. Cody R. J., Laragh J. H. Use of captopril to estimate renin-angiotensin-aldosterone activity in the pathophysiology of chronic heart failure. Am Heart J. 1982 Nov;104(5 Pt 2):1184–1189. doi: 10.1016/0002-8703(82)90049-7. [DOI] [PubMed] [Google Scholar]
  11. Crossley I. R., Bihari D., Gimson A. E., Westaby D., Richardson P. J., Williams R. Effects of converting enzyme inhibitor on hepatic blood flow in man. Am J Med. 1984 May 31;76(5B):62–65. doi: 10.1016/0002-9343(84)90886-6. [DOI] [PubMed] [Google Scholar]
  12. De Jonge A., Wilffert B., Kalkman H. O., Van Meel J. C., Thoolen M. J., Timmermans P. B., Van Zwieten P. A. Captopril impairs the vascular smooth muscle contraction mediated by postsynaptic alpha 2-adrenoceptors in the pithed rat. Eur J Pharmacol. 1981 Sep 24;74(4):385–386. doi: 10.1016/0014-2999(81)90061-3. [DOI] [PubMed] [Google Scholar]
  13. Eriksson L. S., Kågedal B., Wahren J. Effects of captopril on hepatic venous pressure and blood flow in patients with liver cirrhosis. Am J Med. 1984 May 31;76(5B):66–70. doi: 10.1016/0002-9343(84)90887-8. [DOI] [PubMed] [Google Scholar]
  14. Faxon D. P., Creager M. A., Halperin J. L., Bernard D. B., Ryan T. J. Redistribution of regional blood flow following angiotensin-converting enzyme inhibition. Comparison of normal subjects and patients with heart failure. Am J Med. 1984 May 31;76(5B):104–110. doi: 10.1016/0002-9343(84)90895-7. [DOI] [PubMed] [Google Scholar]
  15. Gangar K. F., Vyas S., Whitehead M., Crook D., Meire H., Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet. 1991 Oct 5;338(8771):839–842. doi: 10.1016/0140-6736(91)91500-t. [DOI] [PubMed] [Google Scholar]
  16. Gardiner S. M., Bennett T., Compton A. M. Regional haemodynamic effects of neuropeptide Y, vasopressin and angiotensin II in conscious, unrestrained, Long Evans and Brattleboro rats. J Auton Nerv Syst. 1988 Sep;24(1-2):15–27. doi: 10.1016/0165-1838(88)90131-2. [DOI] [PubMed] [Google Scholar]
  17. Gardiner S. M., Compton A. M., Bennett T., Palmer R. M., Moncada S. Control of regional blood flow by endothelium-derived nitric oxide. Hypertension. 1990 May;15(5):486–492. doi: 10.1161/01.hyp.15.5.486. [DOI] [PubMed] [Google Scholar]
  18. Gardiner S. M., Kemp P. A., Bennett T., Bose C., Foulkes R., Hughes B. Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats. Br J Pharmacol. 1992 Apr;105(4):839–848. doi: 10.1111/j.1476-5381.1992.tb09066.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Gosling R. G., King D. H. Arterial assessment by Doppler-shift ultrasound. Proc R Soc Med. 1974 Jun;67(6 Pt 1):447–449. [PMC free article] [PubMed] [Google Scholar]
  20. Huntsman L. L., Stewart D. K., Barnes S. R., Franklin S. B., Colocousis J. S., Hessel E. A. Noninvasive Doppler determination of cardiac output in man. Clinical validation. Circulation. 1983 Mar;67(3):593–602. doi: 10.1161/01.cir.67.3.593. [DOI] [PubMed] [Google Scholar]
  21. Lees K. R., MacFadyen R. J., Reid J. L. Tissue angiotensin converting enzyme inhibition. Relevant to clinical practice? Am J Hypertens. 1990 Nov;3(11):266S–272S. doi: 10.1093/ajh/3.11s.266s. [DOI] [PubMed] [Google Scholar]
  22. MacFadyen R. J., Lees K. R., Reid J. L. Differences in first dose response to angiotensin converting enzyme inhibition in congestive heart failure: a placebo controlled study. Br Heart J. 1991 Sep;66(3):206–211. doi: 10.1136/hrt.66.3.206. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Mark A. L. The Bezold-Jarisch reflex revisited: clinical implications of inhibitory reflexes originating in the heart. J Am Coll Cardiol. 1983 Jan;1(1):90–102. doi: 10.1016/s0735-1097(83)80014-x. [DOI] [PubMed] [Google Scholar]
  24. Matthews J. N., Altman D. G., Campbell M. J., Royston P. Analysis of serial measurements in medical research. BMJ. 1990 Jan 27;300(6719):230–235. doi: 10.1136/bmj.300.6719.230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Moneta G. L., Taylor D. C., Helton W. S., Mulholland M. W., Strandness D. E., Jr Duplex ultrasound measurement of postprandial intestinal blood flow: effect of meal composition. Gastroenterology. 1988 Nov;95(5):1294–1301. doi: 10.1016/0016-5085(88)90364-2. [DOI] [PubMed] [Google Scholar]
  26. Muller A. F., Gardiner S. M., Compton A. M., Bennett T. Regional haemodynamic effects of captopril, enalaprilat and lisinopril in conscious water-replete and water-deprived Brattleboro rats. Clin Sci (Lond) 1990 Oct;79(4):393–401. doi: 10.1042/cs0790393. [DOI] [PubMed] [Google Scholar]
  27. Qamar M. I., Read A. E., Skidmore R., Evans J. M., Wells P. N. Pulsatility index of superior mesenteric artery blood velocity waveforms. Ultrasound Med Biol. 1986 Oct;12(10):773–776. doi: 10.1016/0301-5629(86)90074-8. [DOI] [PubMed] [Google Scholar]
  28. Qamar M. I., Read A. E., Skidmore R., Evans J. M., Wells P. N. Transcutaneous Doppler ultrasound measurement of superior mesenteric artery blood flow in man. Gut. 1986 Jan;27(1):100–105. doi: 10.1136/gut.27.1.100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Smedes F., Kraak J. C., Poppe H. Simple and fast solvent extraction system for selective and quantitative isolation of adrenaline, noradrenaline and dopamine from plasma and urine. J Chromatogr. 1982 Aug 13;231(1):25–39. doi: 10.1016/s0378-4347(00)80506-x. [DOI] [PubMed] [Google Scholar]
  30. Tesar V., Cervinka J., Kaláb M., Petrtýl J., Temínová P. Vliv jednorázového podání captoprilu na dopplerovsky merený portální průtok. Cas Lek Cesk. 1988 Mar 25;127(13):402–405. [PubMed] [Google Scholar]
  31. Thomaides T. N., Chaudhuri K. R., Mathias C. J. Superior mesenteric artery vascular resistance is higher in hypertensives and is lowered by clonidine. J Hypertens Suppl. 1991 Dec;9(6):S82–S83. [PubMed] [Google Scholar]
  32. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol. 1969 Mar;22(2):158–161. doi: 10.1136/jcp.22.2.158. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Vanhoutte P. M., Auch-Schwelk W., Biondi M. L., Lorenz R. R., Schini V. B., Vidal M. J. Why are converting enzyme inhibitors vasodilators? Br J Clin Pharmacol. 1989;28 (Suppl 2):95S–104S. doi: 10.1111/j.1365-2125.1989.tb03585.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Ventura H. O., Frohlich E. D., Messerli F. H., Kobrin I., Kardon M. B. Cardiovascular effects and regional blood flow distribution associated with angiotensin converting enzyme inhibition (captopril) in essential hypertension. Am J Cardiol. 1985 Apr 1;55(8):1023–1026. doi: 10.1016/0002-9149(85)90739-8. [DOI] [PubMed] [Google Scholar]
  35. Vyas S., Nicolaides K. H., Campbell S. Renal artery flow-velocity waveforms in normal and hypoxemic fetuses. Am J Obstet Gynecol. 1989 Jul;161(1):168–172. doi: 10.1016/0002-9378(89)90257-3. [DOI] [PubMed] [Google Scholar]
  36. WHITNEY R. J. The measurement of volume changes in human limbs. J Physiol. 1953 Jul;121(1):1–27. doi: 10.1113/jphysiol.1953.sp004926. [DOI] [PMC free article] [PubMed] [Google Scholar]
  37. Williams G. H. Converting-enzyme inhibitors in the treatment of hypertension. N Engl J Med. 1988 Dec 8;319(23):1517–1525. doi: 10.1056/NEJM198812083192305. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES